EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Trials of Left Atrial Appendage Closure versus Oral Anticoagulants: An Optimistic View

A John Camm

Thrombosis and Haemostasis · 2026-11 · 126 (11) · 1075-1078

DOI: 10.1055/a-2945-5484 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 06.09.2026. Verfasst von A John Camm. Beteiligte Einrichtung: City St George's University of London, Division of Cardiac and Vascular Sciences, England, United Kingdom of Great Britain and Northern Ireland, Lond…. Hauptthemen laut MEDLINE: Anticoagulants, Left Atrial Appendage Closure, Atrial Fibrillation, Stroke. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombus formation in atrial fibrillation mostly occurs in the left atrial appendage (LAA). LAA closure (LAAC) seems logical to reduce thrombo-embolic AF-related stroke. Early device trials, which predominantly compared LAAC against oral anticoagulant (OAC) with warfarin, showing after 5 years less bleeding and possibly similar ischemic stroke rates with LAAC. New trials (CHAMPION-AF, OPTION, CLUSTER-AF and ASAP TOO) comparing LAAC versus direct OACs, or standard of care for the OAC-intolerant, have reported apparently discordant results, most probably related to the patient phenotype than LAAC itself. Recent meta-analyses, which include new trials have shown that overall, LAAC is followed by less clinically-relevant bleeding but more ischemic but not total strokes. Longer follow-up offsetting penalties related to the implant procedure, more expert implantation and reduced device-related thrombosis should increase the comparative value of LAAC. Meanwhile, LAAC offers therapeutic relief for OAC-intolerant patients or for those wh, understand the outcomes of LAAC and prefer device rather than medical therapy. A change in guideline recommendations should now be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsLeft Atrial Appendage ClosureAtrial FibrillationStrokeAtrial AppendageHumansAdministration, OralTreatment OutcomeThrombosisHemorrhageClinical Trials as TopicPractice Guidelines as Topic

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • City St George's University of London, Division of Cardiac and Vascular Sciences, England, United Kingdom of Great Britain and Northern Ireland, London.

Zitieren

APA

Camm, A. J. (2026). Recent Trials of Left Atrial Appendage Closure versus Oral Anticoagulants: An Optimistic View. Thrombosis and Haemostasis, 126(11), 1075-1078. https://doi.org/10.1055/a-2945-5484

Vancouver

Camm AJ. Recent Trials of Left Atrial Appendage Closure versus Oral Anticoagulants: An Optimistic View. Thrombosis and Haemostasis. 2026;126(11):1075-1078. doi:10.1055/a-2945-5484

BibTeX
@article{Camm2026,
  author = {Camm, A John},
  title = {Recent Trials of Left Atrial Appendage Closure versus Oral Anticoagulants: An Optimistic View},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {11},
  pages = {1075--1078},
  doi = {10.1055/a-2945-5484}
}
Kostenlos starten →